May 11, 2017
H1 Peanut Allergy Market Pipeline latest Pharmaceutical and Healthcare disease pipeline report reviews pipeline therapeutics for Peanut Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources.
May 11, 2017 /MarketersMedia/ —
Market Pipeline Report Peanut Allergy Pipeline Review, H1 2017, provides an overview of the Peanut Allergy (Oncology) pipeline landscape. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Browse the 23 Tables and 11 Figures, 12 Company Profiles, Spread across 84 Pages Report Available at http://www.reportsnreports.com/reports/992907-peanut-allergy-pipeline-review-h1-2017.html .
Peanut Allergy market companies are Adverum Biotechnologies Inc, Aimmune Therapeutics Inc, Alfacyte Ltd, Allergy Therapeutics Plc,AnaptysBio Inc, ASIT Biotech SA, Astellas Pharma Inc, BioLingus AG,DBV Technologies SA,HAL Allergy BV, Intrommune Therapeutics, Sanofi.
All Drug Profiles are Allergen, ANB-020, ANN-004, AR-101, ASP-0892, DBV-712, HALMPE-1, INT-301, PER-1080, pnut-ASIT, Polyvac Peanu, SAR-439794, SCV-204, SCV-209, Vaccine 2, VTC-064.
Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose.
Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=992907
The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 4, 8 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Discovery stages comprises 1, 1 and 1 molecules, respectively.
Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Peanut Allergy (Immunology).
• The pipeline guide reviews pipeline therapeutics for Peanut Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Peanut Allergy (Immunology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Peanut Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Peanut Allergy (Immunology)
Discount of this report http://www.reportsnreports.com/contacts/discount.aspx?name=992907
Reasons to buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Peanut Allergy (Immunology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Peanut Allergy (Immunology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact Info:
Name: Ritesh Tiwari
Email: [email protected]
Organization: ReportsnReports.com
For more information, please visit http://www.reportsnreports.com/reports/992907-peanut-allergy-pipeline-review-h1-2017.html
Source: MarketersMedia
Release ID: 198628
Michael Che is coming back to Netflix with another stand-up special. “Shot in Minnesota,” his third hour for the streamer, will premiere on Oct. 13. Che directed the special, which was taped at First Avenue in Minneapolis. He executive produces with Matthew Vaughan for Rotten Science. “Shot in Minnesota” comes just a couple weeks after […]
EXCLUSIVE: In June, in rural Ohio, 16 children, from toddlers to teenagers were found living in a 12×12 room in conditions so deplorable that authorities described it as “pure evil”. This story is set to be explored in a new feature-length documentary for Oxygen. The Versant-owned cable network has greenlit The Siders 16: Ohio House […]
Law&Crime announced six new series as part of the “Partners in Crime” initiative in collaboration with Court TV. The fall 2026 slate features “Boze vs. The World,” with well-known true-crime digital creator Ericka Bozeman, and “Code 3 with Ashleigh Banfield,” which provides real-time analysis of law enforcement incidents with broadcast journalist Ashleigh Banfield. “Court Junkie,” […]
Ghosts star Rose McIver has hinted that she gave birth, and is explaining how that will impact her role on […] The post ‘Ghosts’ Star Rose McIver Will Be ‘Absent’ From CBS Series to Start Season 6: Here’s Why appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
EXCLUSIVE: James Jordan, who stars alongside Billy Bob Thornton on Paramount+’s Landman, has been tapped for a role in They Follow, David Robert Mitchell’s long-anticipated Neon sequel to his critically acclaimed 2015 horror film It Follows, sources tell Deadline. Reps for Neon declined to comment. Character details are being kept under wraps, as is the […]
Netflix has officially found the leads for its upcoming Icebreaker series! Daisy Jelley and Connor Simos have been cast as […] The post Netflix’s ‘Icebreaker’ Casts Daisy Jelley & Connor Simos as Stassie & Nate appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
What was the second recent strike at a prestigious music institution had jeopardized a European tour. But “the musicians are packing their trunks,” one union rep said.
Chris Olsen says it wasn’t easy writing his recently released memoir, “I Think My Therapist Hates Me,” but he believes it was worth it. “People say, was it cathartic to write it? No, it felt like I was just kind of like stabbing myself over and over again,” the TikTok star told me Sunday at […]
Tomi Adeyemi said in a new interview with The Guardian that she will “never” turn another one of her books into a movie again after her disastrous experience on the set of “Children of Blood and Bone,” the upcoming film adaptation of her 2018 fantasy novel. The best-selling author went viral in late July when […]
EXCLUSIVE: Hugh Laurie is the latest addition to The Trial of Louise Woodward, HBO’s true-crime limited series from creator Matthew Barry. This marks Laurie’s third outing with HBO after Veep and Avenue 5 – both comedies from Armando Iannucci. He joins a cast with Catriona Chandler in the title role. The show also stars Joanne […]
Johnson found fame playing President Trump on “S.N.L.” He hopes a new comedy special shows he has more to offer than just impersonations.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.